PTC Therapeutics Inc
PTCT
NASDAQ
Biotechnology
$71.70
USD
-0.27 (-0.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.01B
Volume 564.3K
Price Target
$85.00 – $108.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $108.00 and a min estimate of $85.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$95.33
+$7.3 vs prior
Implied Upside
+33.0%
+10.2% vs prior
Analyst Covering
3
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$2.33 Gap
Median $93.00 vs avg $95.33 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Benjamin Burnett | Wells Fargo | Buy | Maintained | 3 weeks ago | Plus | Plus | Plus |
Geoff Meacham | Citigroup | Buy | Resumed | 2 months ago | Plus | Plus | Plus |
Faisal Khurshid | Leerink Partners | Buy | Upgraded | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TVTX
Travere Therapeutics Inc
$62.14
▲ +1.2%
ACAD
ACADIA Pharmaceuticals Inc
$28.24
▼ -0.5%
SRRK
Scholar Rock Holding Corp
$52.52
▼ -1.0%
CAI
Caris Life Sciences Inc
$21.80
▼ -1.7%
MIRM
Mirum Pharmaceuticals Inc
$100.64
▲ +1.9%
ERAS
Erasca Inc
$18.38
▲ +2.9%
DYN
Dyne Therapeutics, Inc
$25.70
▼ -1.0%
DNTH
Dianthus Therapeutics Inc
$115.96
▲ +5.8%